Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Duloxetine in the management of diabetic peripheral neuropathic pain.

Ormseth MJ, Scholz BA, Boomershine CS.

Patient Prefer Adherence. 2011;5:343-56. doi: 10.2147/PPA.S16358. Epub 2011 Jul 19.

2.

Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial.

Wernicke JF, Raskin J, Rosen A, Pritchett YL, D'Souza DN, Iyengar S, Knopp K, Le TK.

Curr Ther Res Clin Exp. 2006 Sep;67(5):283-304. doi: 10.1016/j.curtheres.2006.10.001.

3.

Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study.

Chen S, Wu N, Boulanger L, Fraser K, Zhao Z, Zhao Y.

J Med Econ. 2011;14(4):411-20. doi: 10.3111/13696998.2011.585676. Epub 2011 May 26.

PMID:
21615268
4.

Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.

Raskin J, Smith TR, Wong K, Pritchett YL, D'Souza DN, Iyengar S, Wernicke JF.

J Palliat Med. 2006 Feb;9(1):29-40.

PMID:
16430342
5.
6.

Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.

Westanmo AD, Gayken J, Haight R.

Am J Health Syst Pharm. 2005 Dec 1;62(23):2481-90. Review.

PMID:
16303903
7.

Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy.

Wright A, Luedtke KE, Vandenberg C.

J Pain Res. 2010 Dec 16;4:1-10. doi: 10.2147/JPR.S12866.

8.

Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.

Raskin J, Wang F, Pritchett YL, Goldstein DJ.

Pain Med. 2006 Sep-Oct;7(5):373-85.

PMID:
17014595
9.
10.
11.

Diabetic peripheral neuropathic pain: recognition and management.

Cole BE.

Pain Med. 2007 Sep;8 Suppl 2:S27-32. Review.

PMID:
17714113
12.

Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States.

Yang M, Qian C, Liu Y.

Pain Med. 2015 Nov;16(11):2075-83. doi: 10.1111/pme.12845. Epub 2015 Jun 27.

PMID:
26118704
13.

Advances in the management of diabetic peripheral neuropathy.

Tesfaye S.

Curr Opin Support Palliat Care. 2009 Jun;3(2):136-43. doi: 10.1097/SPC.0b013e32832b7df5. Review.

PMID:
19421063
14.

Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.

Irving G, Tanenberg RJ, Raskin J, Risser RC, Malcolm S.

Int J Clin Pract. 2014 Sep;68(9):1130-40. doi: 10.1111/ijcp.12452. Epub 2014 May 18.

PMID:
24837444
15.

Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.

Wu EQ, Birnbaum HG, Mareva MN, Le TK, Robinson RL, Rosen A, Gelwicks S.

J Pain. 2006 Jun;7(6):399-407.

PMID:
16750796
16.

A retrospective pooled analysis of duloxetine safety in 23,983 subjects.

Gahimer J, Wernicke J, Yalcin I, Ossanna MJ, Wulster-Radcliffe M, Viktrup L.

Curr Med Res Opin. 2007 Jan;23(1):175-84.

PMID:
17257478
17.

Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-Analysis.

van Nooten F, Treur M, Pantiri K, Stoker M, Charokopou M.

Clin Ther. 2017 Mar 29. pii: S0149-2918(17)30131-5. doi: 10.1016/j.clinthera.2017.02.010. [Epub ahead of print]

18.

Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Foster RH, Goa KL.

CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010.

PMID:
23338224
19.

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, Raskin J.

Neurology. 2006 Oct 24;67(8):1411-20.

PMID:
17060567
20.

Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?

Marchettini P, Wilhelm S, Petto H, Tesfaye S, Tölle T, Bouhassira D, Freynhagen R, Cruccu G, Lledó A, Choy E, Kosek E, Micó JA, Späth M, Skljarevski V, Lenox-Smith A, Perrot S.

Eur J Pain. 2016 Mar;20(3):472-82. doi: 10.1002/ejp.763. Epub 2015 Aug 27.

PMID:
26311228

Supplemental Content

Support Center